Yes. Amissa supports IRB-approved clinical research by providing secure, de-identified patient data for study purposes.
Helpful Details:
Amissa enables research teams to collect and analyze Apple Watch–derived biometric data alongside patient-reported symptoms—perfect for longitudinal studies or trials. It’s particularly valuable in domains like sleep, mood, cognition, sleep quality, and hot flash tracking.
The platform is built to support full research lifecycles—from study design and participant onboarding to monitoring adherence, data visualization, regulatory compliance (including IRB and NIH standards), and reporting.
Next Steps / Where to Go:
To explore partnerships or request access, reach out to the Amissa research team via their Help Center.
If you'd like to see how the research features work in practice, you can also ask Amissa’s team for a demo or detailed documentation [email protected].